NCT05738694 2026-03-17Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell CarcinomaSun Yat-sen UniversityPhase 3 Recruiting298 enrolled
NCT06364631 2025-01-16CARE1Gustave Roussy, Cancer Campus, Grand ParisPhase 3 Recruiting1,250 enrolled